Combined ultrasound and biochemical screening for Down's syndrome in the first trimester: a Scottish multicentre study.
about
Prenatal screening for trisomy 21: recent advances and guidelinesFirst trimester serum tests for Down's syndrome screeningAntenatal screening for Down's syndrome: generic protocolAntenatal screening for Down's syndromeFirst-trimester screening for Down syndrome in France combining fetal nuchal translucency measurement and biochemical markersThe impact of temporal variability of biochemical markers PAPP-A and free beta-hCG on the specificity of the first-trimester Down syndrome screening: a Croatian retrospective study.Prospective experience with contingent screening strategy for Down syndrome in Estonia.Prediction, prevention and personalisation of medication for the prenatal period: genetic prenatal tests for both rare and common diseasesFirst trimester ultrasound tests alone or in combination with first trimester serum tests for Down's syndrome screening.Antenatal screening for Down syndrome in New Zealand: time for a national screening policy?Regional variations in prenatal screening across Australia: stepping towards a national policy framework.Aneuploidy screening in the first trimester.A prospective two years study of first trimester screening for Down syndromeThe associations of nuchal translucency and fetal abnormalities; significance and implications.Screening for chromosomal abnormalities using combined test in the first trimester of pregnancyThe assessment of nuchal translucency and serum markers for down syndrome screening with ductus venosus Doppler measurements in the first trimester.Reducing inter-rater variability in the assessment of nuchal translucency image quality.Stepwise sequential aneuploidy screening in clinical practice.Uncertainty in nuchal translucency reference ranges at 11-14 weeks of gestation--comparison to Swedish centiles.Trends in the utilization of invasive prenatal diagnosis in The Netherlands during 2000-2009.Delta-NT or NT MoM: which is the most appropriate method for calculating accurate patient-specific risks for trisomy 21 in the first trimester?Population screening for fetal trisomy 21: easy access to screening should be balanced against a uniform ultrasound protocol.Economic modelling of antenatal screening and ultrasound scanning programmes for identification of fetal abnormalities.More invasive procedures are done to detect each case of Down's syndrome in younger women.Audit on nuchal translucency thickness measurements in Flanders, Belgium: a plea for methodological standardization.[Prenatal diagnostics: current medical aspects].A prospective study to assess the clinical impact of interobserver reliability of sonographic measurements of fetal nuchal translucency and crown-rump length on combined first-trimester screening.
P2860
Q22241385-2AFC080C-A4AB-4E62-8D5C-48380EFE16DAQ24187589-0F70DAAA-8120-4DB6-8FAA-7B99174FBCB4Q24236033-3373A71E-C351-424C-A13E-1ACCF9FB1B79Q24241578-3F14B6C6-DB2A-40A8-81C3-E0B655D269C3Q28209561-0D6775B0-78AE-4475-AD60-1BB1B092FC02Q33632633-A1061361-BA0A-4CC2-A661-FFD833095FEFQ35263555-66733994-4594-45FF-AE7C-583534E485E2Q36117899-411DEE5B-A918-4A70-9BE0-C43BF78AFC27Q36308489-F7F6032F-AC13-4B9D-A861-680853B46CC5Q36459548-1FCE92FF-7F6E-48F3-8C32-CA6C95AE9D40Q36585930-CCD0B384-7FCC-4614-B44C-CDD918089A32Q36732309-58561A66-E372-4FF4-A8AA-3908CF8BC9DBQ36869157-7A6C3CB4-F72A-4E1D-B56F-5FD3C78815CFQ36924916-5A5052A7-CA03-47CE-B125-3EB5D326456FQ37266808-638F940F-71C8-4B03-BEFC-88728C02C3F1Q37611181-D5E23393-8C40-4906-8B9E-C1B0A390F7D1Q37867393-D03A4DF9-AFD6-4246-94D4-2D3B5BFEF9C7Q37958816-08727EFC-8CFA-4A8C-94AC-0A86BE55E505Q43654871-070B4C30-616C-438B-A0F0-54F38EC78AC9Q46013175-6A96975E-D299-40BE-A48D-BD6993773A9AQ47706793-589C0A03-F5D6-4980-B305-89C13F8F1321Q50122850-6ECDD6BD-48C5-463D-BDC3-D64A9BE0E5B0Q50129741-A8EB0512-7209-4850-A4F2-467883B1E1B3Q51053067-2EC759BD-DF66-4CA0-A2F3-36B7E27FCF07Q51987712-595A1156-8859-40A7-95F7-17933FA5DC22Q52881355-D0DC9EF9-A57E-4FD8-89A9-0583EF116BC4Q54738038-3EE3CFFB-CE90-4437-8933-908BFA4AEA83
P2860
Combined ultrasound and biochemical screening for Down's syndrome in the first trimester: a Scottish multicentre study.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Combined ultrasound and bioche ...... a Scottish multicentre study.
@en
Combined ultrasound and bioche ...... a Scottish multicentre study.
@nl
type
label
Combined ultrasound and bioche ...... a Scottish multicentre study.
@en
Combined ultrasound and bioche ...... a Scottish multicentre study.
@nl
prefLabel
Combined ultrasound and bioche ...... a Scottish multicentre study.
@en
Combined ultrasound and bioche ...... a Scottish multicentre study.
@nl
P2093
P2860
P1476
Combined ultrasound and bioche ...... a Scottish multicentre study.
@en
P2093
Alan D Cameron
David A Aitken
Elizabeth McBride
J Michael Connor
Jennifer A Crossley
P2860
P304
P356
10.1111/J.1471-0528.2002.01394.X
P577
2002-06-01T00:00:00Z